focus -WSS

focus

author：focus 2025-10-02 17:23:05 - browse：814

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Emergency medicine has repudiated 'excited delirium.' Now what?

focus

WSS

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Physician subsidies by hospitals soar in wake of No Surprises Act

ER docs worry over extreme heat as a 'mass casualty event'

A Theranos scientist

Cassava reveals details — and problems — with Alzheimer's study

15 die by electrocution after transformer explodes in northern India

focus

focus

focus

23andMe had bad news about my health. I wish a person had delivered it

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Peter Hotez and the public health issue of online harassment

Why Sanofi got shellacked over its spinoff

Cancer drug shortages should be causing more outrage

What we know about the American soldier detained in North Korea

Medicare details structure of new drug price negotiation program

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Wildfire smoke exposes gaps in outdoor worker protections

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

leisure time

Medtronic CEO on promising devices for diabetes, hypertension

Twill hunts for pharma partner to market its depression app

House passes resolution saying Israel isn't a 'racist or apartheid state'

More hospitals are billing patients as online messages surge

Diversifying clinical trials isn't enough to close racial gaps: study

Medtronic CEO on promising devices for diabetes, hypertension

focus

focus

focus

entertainment